Aktie A2NB4L TAURIGA SCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Tauriga Sciences, Inc.

Aktien

A2NB4L

US87669X2053

TAUG

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Tauriga Sciences : Amendment to Late Filing Notice (Form NT 10-K/A)
FindThisBest Selects Tauri-Gum as The #1 Best Kosher Chewing Gum in the Overall Marketplace
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event
TAURIGA SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Tauriga Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Tauriga Sciences Inc. Receives its 9,000th E-Commerce Order
Tauriga Sciences Inc. Generates Record Quarterly Net Revenue, from Both Amazon and E-Commerce Business Segment
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska
Tauriga Sciences Inc. Receives Product Endorsement from the State of Alaska
Tauriga Sciences Inc. Set to Report Record Quarterly Net Revenue
Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of Its Corporate Advisory Board
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of its Corporate Advisory Board
Tauriga Sciences : Announces Results of Special Meeting of Shareholders Held on November 22, 2021 - Form 8-K
TAURIGA SCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Tauriga Sciences, Inc. Announces Results of Special Meeting of Shareholders Held on November 22, 2021
Clinical Validation is Completed for New COVID-19 Assay Designed by AEGEA Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2NB4L Aktie
  4. Nachrichten Tauriga Sciences, Inc.
  5. Andere Sprachen